súprava odsávacia 0308
unoplast a/s unovej 1 dk-3390 hundested dánsko -
súprava odsávacia 0309
unoplast a/s unovej 1 dk-3390 hundested dánsko -
súprava odsávacia 0320
unoplast a/s unovej 1 dk-3390 hundested dánsko -
unometer 500 1201
unoplast a/s unovej 1 dk-3390 hundested dánsko -
unometer bag 1202
unoplast a/s unovej 1 dk-3390 hundested dánsko -
unometer bag 1203
unoplast a/s unovej 1 dk-3390 hundested dánsko -
unometer bag 1204
unoplast a/s unovej 1 dk-3390 hundested dánsko -
noliprel forte a
anpharm przedsiebiorstwo farmaceutyczne s.a., poľsko - perindopril a diuretiká - 58 - hypotensiva
prestance 5 mg/5 mg
anpharm przedsiebiorstwo farmaceutyczne s.a., poľsko - perindopril a amlodipín - 58 - hypotensiva
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastické činidlá - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.